XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Operating expenses        
General and administrative $ 1,620,379 $ 1,405,026 $ 4,507,632 $ 3,647,224
Research and development 2,997,634 2,300,277 8,936,969 6,835,700
Total operating expenses (4,618,013) (3,705,303) (13,444,601) (10,482,924)
Other income (expenses)        
Grant income 74,528 69,146 74,528 121,116
Research and development incentive income 1,629,513 1,629,513 2,022,902
Interest income, net 112,226 26,677 171,249 48,479
Gain on settlement of accounts payable 75,204 75,204
Financing related charges (30,943) (30,943)
Foreign exchange gain (16,475) (65,932) (22,833) (40,128)
Total other income 1,768,849 105,095 1,821,514 2,227,573
Net loss before provision for income taxes (2,849,164) (3,600,208) (11,623,087) (8,255,351)
Income tax expense (9,877) (37,266) (50,480)
Net loss and comprehensive loss $ (2,849,164) $ (3,610,085) $ (11,660,353) $ (8,305,831)
Loss per share        
Basic and diluted (in dollars per share) $ (0.06) $ (0.04) $ (0.26) $ (0.12)
Weighted average number of shares outstanding        
Basic and diluted (in shares) 45,212,074 41,509,225 44,365,683 40,344,149